Carregant...
Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report
We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under‐recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.
Guardat en:
| Publicat a: | Clin Case Rep |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8190675/ https://ncbi.nlm.nih.gov/pubmed/34136239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.4305 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|